A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headache

American Journal of Emergency Medicine

Volumn 31, Issue 3, 2013, Pages 540-544

  Bakhshayesh, Babak ^a   Seyed Saadat, Seyed Mohammad ^b   Rezania, Kourosh ^c   Hatamian, Hamidreza ^a   Hossieninezhad, Mozaffar ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METOCLOPRAMIDE; SUMATRIPTAN; VALPROIC ACID;

ADULT; ANALGESIA; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FLUSHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITHOUT AURA; NAUSEA; OUTCOME ASSESSMENT; PHONOPHOBIA; PHOTOPHOBIA; PRIORITY JOURNAL; PROLONGED ACUTE MIGRAINE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

ACUTE DISEASE; ADULT; ANALGESICS; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; FEMALE; GABA AGENTS; HUMANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MALE; METOCLOPRAMIDE; MIGRAINE WITHOUT AURA; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SEROTONIN 5-HT1 RECEPTOR AGONISTS; SEVERITY OF ILLNESS INDEX; SUMATRIPTAN; TREATMENT OUTCOME; VALPROIC ACID;

EID: 84875430490     PISSN: 07356757     EISSN: 15328171     Source Type: Journal    
DOI: 10.1016/j.ajem.2012.10.014     Document Type: Article

References (34)

1. S.J. Tepper, and R.C. Spears Acute treatment of migraine Neurol Clin 27 2009 417 427
2. P.J. Goadsby, R.B. Lipton, and M.D. Ferrari Migraine - current understanding and treatment N Engl J Med 346 2002 257 270
3. L. Stovner, K. Hagen, R. Jensen, Z. Katsarava, R.B. Lipton, and A. Scher The global burden of headache: a documentation of headache prevalence and disability worldwide Cephalalgia 27 2007 193 210
4. M.E. Bigal, and R.B. Lipton The epidemiology burden, and comorbidities of migraine Neurol Clin 27 2009 321 334
5. W.F. Stewart, M.E. Bigal, and R.B. Lipton Lifetime migraine incidence. Results from the American Migraine Prevalence and Prevention study Headache 46 2005 52 55
6. K.R. Edwards, J. Norton, and M. Behnke Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache Headache 41 2001 976 980
7. S.D. Silberstein Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology 2000 55
8. E. Loder Triptan therapy in migraine N Engl J Med 363 2010 63 70
9. P. Tfelt-Hansen, P.D. Vries, and P.R. Saxena Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy Drugs 60 2000 1259 1287
10. M. Callaham, and N. Raskin A controlled study of dihydroergotamine in the treatment of acute migraine headache Headache 26 1986 168 171
11. C. Derry, S. Derry, and R. Moore Sumatriptan (oral route of administration) for acute migraine attacks in adults (Review) Cochrane Database Syst Rev 2012
12. F. Freitag, G. Finlayson, A. Rapoport, A. Elkind, M. Diamond, and J. Unger Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS) Headache 47 2007 519 530
13. J. Pascual, and X. Cabarrocas Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better Headache 42 2002 28 31
14. P.J. Goadsby, G. Zanchin, G. Geraud, N.D. Klippel, S. Diaz-Insa, and H. Gobel Early vs. non-early intervention in acute migraine - 'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan Cephalalgia an international journal of headache 28 2008 383 391
15. S. Evers, J. Afra, A. Frese, P.J. Goadsby, A. May, and P.S. Sandor EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force Eur J Neurol 16 2009 968 981
16. I. Colman, M.D. Brown, G.D. Innes, E. Grafstein, T.E. Roberts, and B.H. Rowe Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials BMJ 329 2004 1369 1373
17. J. Klapper Divalproex sodium in migraine prophylaxis: a dose-controlled study Cephalalgia 17 1997 103 108
18. N.T. Mathew, J. Kailasam, L. Meadors, O. Chernyschev, and P. Gentry Intravenous valproate sodium (Depacon) aborts migraine rapidly: a preliminary report Headache 40 2000 720 723
19. F. Cutrer, V. Limmroth, and M. Moskowitz Possible mechanisms of valproate in migraine prophylaxis Cephalalgia 17 1997 93 100
20. R. Shahien, S.A. Saleh, and A. Bowirrat Intravenous sodium valproate aborts migraine headaches rapidly Acta Neurol Scand 123 2011 257 265
21. T. Leniger, L. Pageler, P. Stude, H.C. Diener, and V. Limmroth Comparison of intravenous valproate with intravenous lysine-acetylsalicylic acid in acute migraine attacks Headache 45 2005 42 46
22. D.A. Tanen, S. Miller, T. French, and R.H. Riffenburgh intravenous sodium valproate versus prochlorperazine for the emergency department treatment of acute migraine headaches: a prospective, randomized, double-blind trial Ann Emerg Med 41 2003 847 853
23. C. Lampl, G. Huber, S. Haas, G. Rittberger, and H. Diener Difference in triptan effect in patients with migraine and early allodynia Cephalalgia 28 2008 1031 1038
24. M.W. Weatherall, A.J. Telzerow, E. Cittadini, H. Kaube, and P.J. Goadsby Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache Neurology 75 2010 1098 1103
25. K.H. Todd, K.G. Funk, J.P. Funk, and R. Bonacci Clinical significance of reported changes in pain severity Ann Emerg Med 27 1996 485 489
26. E.J. Gallagher, M. Liebman, and P.E. Bijur Prospective validation of clinically important changes in pain severity measured on a visual analog scale Ann Emerg Med 38 2001 633 638
27. M.J. Stillman, D. Zajac, and L.A. Rybicky Treatment of primary headache disorders with intravenous valproate: initial outpatient experience Headache 44 2004 65 69
28. T.H. Schwartz, V.V. Karpitskiy, and R.S. Sohn Intravenous valproate sodium in the treatment of daily headache Headache 42 2002 519 522
29. J. Norton Use of intravenous valproate sodium in status migraine Headache 40 2000 755 757
30. M.A. Kostic, F.J. Gutierrez, T.S. Rieg, T.S. Moore, and R.T. Gendron A prospective, randomized trial of intravenous prochlorperazine versus subcutaneous sumatriptan in acute migraine therapy in the emergency department Ann Emerg Med 2010 56
31. B.W. Friedman, J. Corbo, R.B. Lipton, P.E. Bijur, D. Esses, and C. Solorzano A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines Neurology 64 2005 463 468
32. B.E. Akpunonu, A.B. Mutgi, D.J. Federman, F.G. Volinsky, K. Brickman, and R.L. Davis Subcutaneous sumatriptan for treatment of acute migraine in patients admitted to the emergency department: a multicenter study Ann Emerg Med 25 1995 464 469
33. J.T. Meredith, S. Wait, and K.L. Brewer A prospective double-blind study of nasal sumatriptan versus IV ketorolac in migraine Am J Emerg Med 21 2003 173 175
34. P. Burke-Ramirez, M. Asgharnejad, C. Webster, R. Davis, and A. Laurenza Efficacy and tolerability of subcutaneous sumatriptan for acute migraine: a comparison between ethnic groups Headache 41 2001 873 882